SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report)’s stock price was down 1.2% on Friday . The stock traded as low as $24.38 and last traded at $24.38. Approximately 200 shares traded hands during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Performance
The company has a 50-day simple moving average of $24.38 and a two-hundred day simple moving average of $24.38. The stock has a market cap of $6.64 billion, a price-to-earnings ratio of 48.76, a price-to-earnings-growth ratio of 1.30 and a beta of 1.81.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B.
Featured Articles
- Five stocks we like better than SWEDISH ORPHAN/S
- 3 Defense Stocks Set to Benefit From Increased Military Spending
- Rocket Lab’s Big Rebound? Analysts Suggest the Dip’s a Gift
- Why Invest in High-Yield Dividend Stocks?
- Meta’s AI Moment? New SAM 3 Model Has Wall Street Turning Bullish
- High Flyers: 3 Natural Gas Stocks for March 2022
- Snowflake Stock: The Dip That Smart Investors Are Buying Right Now
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
